Pharma, Biopharma & Advanced Modalities
Independent Technical Stewardship for India’s Life Sciences Ecosystem
Pharma, Biopharma & Advanced Modalities
India has emerged as a preferred destination for cost-effective, high-quality pharma and biopharma development and manufacturing. With world-class capabilities across small molecules, biologics, and emerging modalities, Indian partners can deliver innovation at speed. However, success depends not just on access to capability-but on choosing the right partners and actively managing technical, regulatory, and execution risk.
Aventiq Bio bridges global innovators with India’s top-tier ecosystem through independent technical governance. We provide partner scouting and qualification, due diligence, tech-transfer oversight, regulatory and quality advisory, and program-level governance across the lifecycle. Our model ensures your programs remain audit-ready, globally compliant, and scientifically defensible-while capturing 40–60% cost advantages without compromise.
Our Specialized Expertise by Modality
Small Molecules
Bridging the gap between lab-scale discovery and GMP reality. We provide the independent vetting and on-ground governance required to navigate India’s ecosystem with absolute certainty. We offer the full small molecule lifecycle-from target validation.
+ Read MoreHPAPI (Highly Potent APIs)
Aventiq Bio provides the technical governance required to tap into India’s elite HPAPI capacity with absolute safety, regulatory certainty, and 40–60% cost advantages. We don't just find you a manufacturer; we build a firewall around your potent IP and your global reputation.
+ Read MoreBiologics & mAbs (Monoclonal Antibodies)
From cell line development to commercial scale-up - Aventiq Bio provides independent technical governance for mAbs, recombinant proteins, and biosimilars in India’s leading biopharma hubs
+ Read MoreADCs (Antibody-Drug Conjugates)
ADCs are the most complex modalities in modern medicine. Managing the fragile intersection of potent Cytotoxic Payload synthesis and delicate protein conjugation requires more than a vendor - it requires Integrated Governance.
Cell & Gene Therapy (CGT) – Advisory Only
ADCs are the most complex modalities in modern medicine. Managing the fragile intersection of potent Cytotoxic Payload synthesis and delicate protein conjugation requires more than a vendor - it requires Integrated Governance.
+ Read MoreVaccines
Vaccine programs demand flawless execution at unprecedented scale, yet outsourcing to high-volume facilities introduces risks: lot variability, cold chain breaks, and aseptic breaches that can compromise immunogenicity or trigger recalls.
+ Read MorePrecision Medicine & Genomics
Aventiq Bio serves as your Independent Technical Proxy in India. We provide high-level governance for NGS platforms, biomarkers, and Companion Diagnostics (CDx), ensuring that genomics-driven programs are built on audit-ready data and defensible partner intelligence.
Read MoreOur Governance & Advisory Services for Pharma & Biopharma
Expert consulting for partner selection, tech transfer oversight, regulatory compliance, and end-to-end project governance across complex modalities.
-
Partner Scouting & Due Diligence :
Independent evaluation and qualification of 500+ CRO/CDMO and manufacturing facilities across India
-
Tech Transfer & Process Oversight :
Governance of scale-up, validation, and inter-site hand-offs to ensure reproducibility and compliance
-
Regulatory & Quality Advisory
Strategic support for FDA/EMA-aligned filings, audit readiness, and ALCOA+ data integrity.
-
Program Governance & Risk Management
Centralized oversight of timelines, costs, vendors, and risk across the development lifecycle.
